Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis-Reference-Cited by-同舟云学术

Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis

Published:2018-05-18 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Dorraji S. Esmaeil^ORCID,Hovd Aud-Malin K.,Kanapathippillai Premasany,Bakland Gunnstein,Eilertsen Gro Østli,Figenschau Stine L.^ORCID,Fenton Kristin A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-26265-z.pdf

Reference83 articles.

1. Moulton, V. R. et al. Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective. Trends Mol. Med 23, 615–635 (2017).

2. Murata, H. et al. T cell receptor repertoire of T cells in the kidneys of patients with lupus nephritis. Arthritis Rheum 46, 2141–2147 (2002).

3. Davidson, A. What is damaging the kidney in lupus nephritis? Nat Rev Rheumatol 12, 143–153 (2016).

4. Chang, A. et al. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J. Immunol 186, 1849–1860 (2011).

5. Kang, S. et al. BAFF Induces Tertiary Lymphoid Structures and Positions T Cells within the Glomeruli during Lupus Nephritis. J Immunol 198, 2602–2611 (2017).

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Stem and Progenitor Cells Can Affect Renal Diseases;Cells;2024-08-30

2. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances;Signal Transduction and Targeted Therapy;2024-08-28

3. The PP2A inhibitor LB-100 mitigates lupus nephritis by suppressing tertiary lymphoid structure formation;European Journal of Pharmacology;2024-08

4. Lymphocyte homing and recirculation with tumor tertiary lymphoid structure formation: predictions for successful cancer immunotherapy;Frontiers in Immunology;2024-07-15

5. Epigenetic targets to enhance antitumor immune response through the induction of tertiary lymphoid structures;Frontiers in Immunology;2024-01-25